Boston Scientific Reports $20B in Net Sales for 2025, Governance Proposals Pass
At its annual general meeting on May 2, Boston Scientific reported net sales of $20 billion for 2025 with mid-teens growth and over $2 billion invested in R&D. Shareholders approved key governance measures including the re-election of all directors and amendments to corporate bylaws.
Topics: financial_performance governance_votes legal_litigation